title: [Clinical assessment of myocardial protection utilizing crystalloid cardioplegia in neonates and infants--analysis with myocardial ultrastructures].
authors.forename: Y
authors.initials: Y
authors.lastname: Sawa
authors.forename: H
authors.initials: H
authors.lastname: Matsuda
authors.forename: Y
authors.initials: Y
authors.lastname: Shimazaki
authors.forename: M
authors.initials: M
authors.lastname: Ohtani
authors.forename: K
authors.initials: K
authors.lastname: Kadoba
authors.forename: H
authors.initials: H
authors.lastname: Takami
authors.forename: H
authors.initials: H
authors.lastname: Hirose
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
authors.forename: S
authors.initials: S
authors.lastname: Onishi
authors.forename: T
authors.initials: T
authors.lastname: Nakada
mesh_terms: D000367:Age Factors; D005947:Glucose / Q000008:administration & dosage / Q000009:adverse effects; D006324:Heart Arrest, Induced / Q000379:methods*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D008929:Mitochondria, Heart / Q000648:ultrastructure; D009206:Myocardium / Q000648:ultrastructure*; D011188:Potassium / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium